The Percentage of [−2]Pro–Prostate-Specific Antigen and the Prostate Health Index Outperform Prostate-Specific Antigen and the Percentage of Free Prostate-Specific Antigen in the Detection of Clinically Significant Prostate Cancer and Can Be Used as Reflex Tests

Context.—: There is a need to avoid the overdiagnosis of prostate cancer (PCa) and to find more specific biomarkers. Objective.—: To evaluate the clinical utility of [-2]pro-prostate-specific antigen ([-2]proPSA) derivatives in detecting clinically significant PCa (csPCa) and to compare it with pros...

Full description

Bibliographic Details
Main Author: Garrido, MM (author)
Other Authors: Marta, JC (author), Bernardino, RM (author), Guerra, J (author), Fernandes, F (author), Pereira, MH (author), Ribeiro, R (author), Holdenrieder, S (author), Pinheiro, LC (author), Guimarães, JT (author)
Format: article
Language:eng
Published: 2022
Subjects:
Prostate-Specific Antigen
Prostate Cancer
HSJ PAT CLIN
HSJ ANPAT
Online Access:http://hdl.handle.net/10400.17/4104
Country:Portugal
Oai:oai:repositorio.chlc.min-saude.pt:10400.17/4104

Internet

http://hdl.handle.net/10400.17/4104

Similar Items